Navigation Links
PCMA Launches New Oregon Ad Campaign: 'That's What PBMs Do'
Date:2/6/2012

WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) launched a new ad campaign in Oregon that highlights the core value proposition of pharmacy benefit managers (PBMs).  The ad campaign – "That's What PBMs Do" – focuses on key themes including:

  • PBMs lower costs for employers, unions, and consumers
  • PBM mail-service pharmacies improve safety, savings, and convenience
  • PBMs help patients make informed prescription drug decisions and improve adherence.

"This ad campaign will educate key Oregon decision makers about the important savings and safety benefits PBMs provide to employers, unions, and consumers," said PCMA President and CEO Mark Merritt. 

Click here to view the new ads.

PBMs will save Oregon consumers and payers $20 billion in prescription drug costs – a 35 percent savings – over the next decade.  Nationally, PBMs will save consumers and payers, including Medicare Part D, almost $2 trillion in prescription drug costs over the next decade, according to new research from Visante.

In addition to the ad campaign, a new PCMA video highlights the innovative tools and programs PBMs use to make prescription medications safer and more affordable for more than 215 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.

View the new video here. 

PBMs improve safety and savings in several ways:

  • Negotiating Discounts from Drugstores and Drug Manufacturers: Retail pharmacies provide discounts to be included in a plan's pharmacy network.  The more selective the network, the greater the
    '/>"/>

SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2012)... LOS ANGELES, May 16, 2012  NeuroSigma, Inc., ... that its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired ... covering the fabrication of Thin-Film Nitinol (TFN) from ... entitled "Three Dimensional Thin Film Devices and Methods ... covering the production of three-dimensional TFN constructs. ...
(Date:5/16/2012)... Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its ... six different unmatched strains of H5N1 in a phase ... Inovio,s path to develop universal influenza vaccines. By design, ... single virus. Importantly, the vaccine generated a hemagglutination inhibition ... one of the six tested H5N1 strains in 8 ...
(Date:5/15/2012)... May 15, 2012  Nile Therapeutics, Inc. (OTCQB: NLTX), ... failure patients, today announced its first quarter financial results ... of 2012, Nile reported a net operating loss of ... for the quarter were 39.7 million. Nile reported collaboration ... 31, 2012. As of March 31, ...
Breaking Medicine Technology:NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 2NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 3Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial 2Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial 3Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial 4Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial 5Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial 6Nile Therapeutics Reports 2012 First Quarter Financial Results 2Nile Therapeutics Reports 2012 First Quarter Financial Results 3Dr Dispense Chooses World 26apos 3Bs First Fully Automated Managed Hosting Solution from StrataScale for All Outsourcing Needs 68589 1Dr Dispense Chooses World 26apos 3Bs First Fully Automated Managed Hosting Solution from StrataScale for All Outsourcing Needs 68589 2Dr Dispense Chooses World 26apos 3Bs First Fully Automated Managed Hosting Solution from StrataScale for All Outsourcing Needs 68589 3Go Beyond Retro to Discover the World of 20th Century Fashion 21 68585 1Go Beyond Retro to Discover the World of 20th Century Fashion 21 68585 2Autologous Bone Marrow Stem Cells Transplant into Parkinson 26apos 3Bs Disease Patients is Safe and May Improve Their Quality of Life 68582 1Autologous Bone Marrow Stem Cells Transplant into Parkinson 26apos 3Bs Disease Patients is Safe and May Improve Their Quality of Life 68582 2
... and US Partner Forest Laboratories, Inc. Today,Announced the ... Acute,Ischemic Stroke) Study with the Compound Desmoteplase , ... (Frankfurt Stock,Exchange, Prime Standard: PA8) and its US ... results of,the DIAS-2 (Desmoteplase In Acute Ischemic Stroke) ...
... of the Results, ISTA Plans to Initiate,Phase III Studies ... 31, 2007 /PRNewswire-FirstCall/ -- ISTA,Pharmaceuticals, Inc. , today announced ... IIb clinical study of,ecabet sodium, which is being developed ... ecabet sodium group achieved a strong,trend in the objective ...
Other Medicine Technology:Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5
(Date:5/16/2012)... -- Heart palpitations and high blood pressure are strong ... atrial fibrillation, a new study reports. Atrial fibrillation ... death. It was already known that high blood pressure ... to the researchers, this is the first study to ... are commonly felt as a rapid or strong irregular ...
(Date:5/15/2012)... Hispanic Americans are far more likely than whites to ... Researchers analyzed data from more than 5,000 men and ... colonoscopy screening at New York-Presbyterian Hospital/Columbia University Medical Center ... of the patients had signs or symptoms of colorectal ... At least one precancerous polyp was detected in 26 ...
(Date:5/15/2012)... continues to take its toll on Americans, with almost ... in 2010, according to a report released Tuesday by ... The CDC analysis also found that more than 29 ... with the illness at some point in their lifetime. ... wheezing and discomfort of asthma. According to the ...
(Date:5/15/2012)... Older, sicker, high-risk patients who undergo one of ... results in larger, busier hospitals, according to new research ... same research showed the experience level of the surgeon ... setting. , The results, based on data gathered throughout ... American Urological Association Annual Meeting in Atlanta. , It ...
(Date:5/15/2012)... increasing number of highly educated women are opting for ... University at Buffalo economist. , Qingyan Shang, an assistant ... be the reversal of a trend by highly educated ... to be certain, but the research clearly shows fertility ... (Fertility is defined as the number of children a ...
Breaking Medicine News(10 mins):Health News:Palpitations May Signal Future Heart Rhythm Problem 2Health News:Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought 2Health News:Asthma Cases Continue to Rise in U.S., Affecting Millions 2Health News:Asthma Cases Continue to Rise in U.S., Affecting Millions 3Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2Health News:For highly educated women, families are an increasingly popular option 2
... the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported ... watchful waiting after a median of 8.2 years of ... Sweden the results after 3 more years of follow-up ... , The SPCG-4 trial which predominantly included ...
... more than one year after it was created, the ... of Texas M. D. Anderson Cancer Center has ... aimed at inspiring generations of women scientists to come.Legends ... at M. D. Anderson Cancer Center presents the reflections ...
... 2009 Forest Laboratories, Inc. (NYSE: FRX ... Administration (FDA) has approved the Company,s supplemental New Drug ... and maintenance treatment of Major Depressive Disorder (MDD) in ... only the second antidepressant to be approved for the ...
... treatments for cognitive disorders, researchers say , , FRIDAY, ... functions on "the edge of chaos," at a ... U.K.-based researchers who said their finding could help ... , The researchers used medical imaging to ...
... MEDICAL CORP. (NYSE: CMN ) announced the ... President and Chief Executive Officer. Mr. Krakauer will also ... Cantel in September 2004, Mr. Krakauer served as Executive Vice ... Board concurrently appointed Seth R. Segel, Senior Vice President - ...
... Today, the Migraine Research Foundation (MRF) announced a new ... adolescent migraine called FOR OUR CHILDREN. The new ... the understanding of migraine and its causes and treatments ... , Migraine is very common in children ...
Other Medicine News:Health News:SPCG-4 trial: Update on watchful waiting versus radical prostatectomy 2Health News:New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer 2Health News:New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer 3Health News:New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer 4Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 2Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 3Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 4Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 5Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 6Health News:Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments 2Health News:New initiative to support pediatric migraine research is announced 2
... highly accurate portable system for pH, mV (ORP), ... results can be obtained when used with a ... This GLP/GMP compliant system includes an RS-232 interface ... Up to 100 data sets can be stored ...
... 265 is a highly accurate portable, waterproof system ... measurements. Temperature compensated pH results can be obtained ... a 3-in-1 electrode. • This GLP/GMP compliant system ... printer or a computer. Up to 100 data ...
... compressor. Triple pane thermal glass. Self-closing ... No plumbing required. Equipped with a 9 ... Parts & Labor and an Additional 4 Year ... a chromatography unit which includes two access ports ...
... shelves. Over-sized compressor. Triple pane thermal ... Self-Contained System No plumbing required. Equipped ... Year Warranty on Parts & Labor and an ... Also available as a chromatography unit which includes ...
Medicine Products: